The goal of this activity is for learners to be better able to decipher the role of systemic inflammation in the development of atherosclerotic cardiovascular disease (ASCVD) and evaluate current and emerging therapeutic strategies to address residual inflammatory risk for cardiovascular risk reduction, and apply learnings into the care of patients with heightened inflammatory risk to optimize patient care and outcomes.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1001428
- Start Date: 2024-08-08 05:00:00
- End Date: 2024-08-08 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours - Commercial Support: Source: Novo Nordisk - Amount: 43910.0 - Is Kind Support: False
- Activity Type: Other/Blended Learning
- CME Finder Type: Other
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest